214 related articles for article (PubMed ID: 7694424)
1. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate.
Bonkhoff H; Stein U; Remberger K
Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):291-4. PubMed ID: 7694424
[TBL] [Abstract][Full Text] [Related]
2. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1995 Feb; 26(2):167-70. PubMed ID: 7532147
[TBL] [Abstract][Full Text] [Related]
3. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H; Remberger K
Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
[TBL] [Abstract][Full Text] [Related]
5. Do neuroendocrine cells in human prostate cancer express androgen receptor?
Krijnen JL; Janssen PJ; Ruizeveld de Winter JA; van Krimpen H; Schröder FH; van der Kwast TH
Histochemistry; 1993 Nov; 100(5):393-8. PubMed ID: 8307781
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
Bonkhoff H
Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
[TBL] [Abstract][Full Text] [Related]
7. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate.
Bonkhoff H; Wernert N; Dhom G; Remberger K
Prostate; 1991; 19(2):91-8. PubMed ID: 1717965
[TBL] [Abstract][Full Text] [Related]
8. Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity.
Roudier MP; True LD; Vessella RL; Higano CS
J Clin Pathol; 2004 Mar; 57(3):321-3. PubMed ID: 14990610
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate.
Schmid KW; Helpap B; Tötsch M; Kirchmair R; Dockhorn-Dworniczak B; Böcker W; Fischer-Colbrie R
Histopathology; 1994 Mar; 24(3):233-9. PubMed ID: 7515371
[TBL] [Abstract][Full Text] [Related]
10. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation.
Bonkhoff H; Stein U; Welter C; Remberger K
Hum Pathol; 1995 Aug; 26(8):824-8. PubMed ID: 7635445
[TBL] [Abstract][Full Text] [Related]
12. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.
Mosca A; Berruti A; Russo L; Torta M; Dogliotti L
J Endocrinol Invest; 2005; 28(11 Suppl International):141-5. PubMed ID: 16625864
[TBL] [Abstract][Full Text] [Related]
13. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
Bonkhoff H; Remberger K
Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
15. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1994 Jan; 25(1):42-6. PubMed ID: 7508883
[TBL] [Abstract][Full Text] [Related]
16. BAG-1 expression in hyperplastic and neoplastic prostate tissue: is there any relationship with BCL-related proteins and androgen receptor status?
Bozdogan O; Atasoy P; Bozdogan N; Erekul S; Batislam E; Yilmaz E; Başar MM
Tumori; 2005; 91(6):539-45. PubMed ID: 16457154
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.
Noordzij MA; van Steenbrugge GJ; van der Kwast TH; Schröder FH
Urol Res; 1995; 22(6):333-41. PubMed ID: 7740652
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer.
Mosca A; Dogliotti L; Berruti A; Lamberts SW; Hofland LJ
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S60-7. PubMed ID: 15077913
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status.
Bonkhoff H
Ann Oncol; 2001; 12 Suppl 2():S141-4. PubMed ID: 11762342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
